HCA HealthcareHCA
紐約證券 · USD
353.92
-1.14
(-0.32%)
收盤 08/01 03:59 (UTC+8)
盤後
353.55
353.55
(-0.10%)
08/01 03:59 (UTC+8)
HCA HealthcareHCA
353.92
-1.14
(-0.32%)
財務數據
損益表
- 154.97
- 155.91
- 158.61
- 162.13
- 173.03
- 173.39
- 174.92
- 174.87
- 182.85
- 183.21
- 3.51
- 0.61
- 1.73
- 2.22
- 6.72
- 0.21
- 0.88
- -0.03
- 4.56
- 0.20
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 18,321,000 | 18,285,000 | 17,487,000 | 17,492,000 | 17,339,000 | 17,303,000 | 16,213,000 | 15,861,000 | 15,591,000 | 15,497,000 |
營業成本 | 2,764,000 | 2,793,000 | 2,657,000 | 2,634,000 | 2,671,000 | 2,584,000 | 2,417,000 | 2,478,000 | 2,423,000 | 2,429,000 |
營業毛利 | 15,557,000 | 15,492,000 | 14,830,000 | 14,858,000 | 14,668,000 | 14,719,000 | 13,796,000 | 13,383,000 | 13,168,000 | 13,068,000 |
營業費用 | - | 12,646,000 | 12,420,000 | 12,127,000 | 12,108,000 | 11,918,000 | 11,704,000 | 11,083,000 | 10,734,000 | 10,655,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 11,842,000 | 11,790,000 | 11,578,000 | 11,308,000 | 11,313,000 | 11,129,000 | 10,935,000 | 10,320,000 | 9,978,000 | 9,905,000 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 860,000 | 856,000 | 842,000 | 819,000 | 795,000 | 789,000 | 769,000 | 763,000 | 756,000 | 750,000 |
營業利益 | 2,855,000 | 2,846,000 | 2,410,000 | 2,731,000 | 2,560,000 | 2,801,000 | 2,092,000 | 2,300,000 | 2,434,000 | 2,413,000 |
其他收入及費用 | 1,000 | -195,000 | -4,000 | 12,000 | 201,000 | 7,000 | 2,000 | 1,000 | -15,000 | 1,326,000 |
利息費用 | 547,000 | 528,000 | 515,000 | 506,000 | 512,000 | 491,000 | 483,000 | 485,000 | 479,000 | 453,000 |
稅前純益 | 2,327,000 | 2,133,000 | 1,906,000 | 2,237,000 | 2,247,000 | 2,345,000 | 1,630,000 | 1,809,000 | 1,922,000 | 3,302,000 |
所得稅 | 502,000 | 447,000 | 424,000 | 550,000 | 445,000 | 484,000 | 355,000 | 397,000 | 379,000 | 656,000 |
稅後純益 | 1,610,000 | 1,438,000 | 1,270,000 | 1,461,000 | 1,591,000 | 1,607,000 | 1,079,000 | 1,193,000 | 1,363,000 | 2,081,000 |
基本每股稅後盈餘(元) | 6.63 | 5.75 | 4.94 | 5.60 | 6.01 | 6.05 | 3.98 | 4.35 | 4.92 | 7.50 |
稀釋每股稅後盈餘(元) | 6.45 | 5.63 | 4.90 | 5.54 | 5.93 | 5.90 | 3.93 | 4.29 | 4.85 | 7.18 |
基本平均股數(千股) | 242955.00 | 249981.00 | 256763.00 | 261156.00 | 264435.00 | 265537.00 | 271173.00 | 274494.00 | 276910.00 | 277378.00 |
稀釋平均股數(千股) | 249440.00 | 255310.00 | 259917.00 | 264071.00 | 268016.00 | 271186.00 | 275424.00 | 278198.00 | 280961.00 | 285663.00 |
還原基本每股稅後盈餘(元) | 6.63 | 5.75 | 4.94 | 5.60 | 6.01 | 6.05 | 3.98 | 4.35 | 4.92 | 7.50 |
還原稀釋每股稅後盈餘(元) | 6.45 | 5.63 | 4.90 | 5.54 | 5.93 | 5.90 | 3.93 | 4.29 | 4.85 | 7.18 |
還原基本平均股數(千股) | 242,955 | 249,981 | 256,763 | 261,156 | 264,435 | 265,537 | 271,173 | 274,494 | 276,910 | 277,378 |
還原稀釋平均股數(千股) | 249,440 | 255,310 | 259,917 | 264,071 | 268,016 | 271,186 | 275,424 | 278,198 | 280,961 | 285,663 |
EBITDA(千元) | 3,530,000 | 3,278,000 | 3,060,000 | 3,344,000 | 3,352,000 | 3,380,000 | 2,695,000 | 2,846,000 | 2,986,000 | 3,947,000 |